Jose Castillo

Dr. Jose Castillo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KSKhadija Soufi
Khadija Soufi
JCJose Castillo
Jose Castillo
FRFreddie Y. Rogdriguez
Freddie Y. Rogdriguez
CMCharles John De Mesa
Charles John De Mesa
Julius O. EbinuJulius O. Ebinu
Julius O. Ebinu
Back pain is the single leading cause of disability worldwide. Despite the prevalence and morbidity of lower back pain, we still lack a gold-standard treatment that restores the physiological function of degenerated intervertebral discs. Recently, stem cells have emerged as a promising strategy for regenerative therapy for degenerative disc disease. In this study, we review the etiology, pathogenesis, and developing treatment strategies for disc degeneration in low back pain with a focus on regenerative stem cell therapies. A systematic search of PubMed/MEDLINE/Embase/Clinical Trials.gov databases was conducted for all human subject abstracts or studies. There was a total of 10 abstracts and 11 clinical studies (1 RCT) that met the inclusion criteria. The molecular mechanism, approach, and progress of the different stem cell strategies in all studies are discussed, including allogenic bone marrow, allogenic discogenic cells, autologous bone marrow, adipose mesenchymal stem cells (MSCs), human umbilical cord MSC, adult juvenile chondrocytes, autologous disc derived chondrocytes, and withdrawn studies. Clinical success with animal model studies is promising; however, the clinical outcomes of stem cell regenerative therapy remain poorly understood. In this systematic review, we found no evidence to support its use in humans. Further studies on efficacy, safety, and optimal patient selection will establish whether this becomes a viable, non-invasive therapeutic option for back pain.

31 January 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
ANAva Nazeri
Ava Nazeri
JCJose Castillo
Jose Castillo
AGArash Ghaffari-Rafi
Arash Ghaffari-Rafi
Background/Objectives: Molar distalization with clear aligners is increasingly used for Class II malocclusions, yet the associated periodontal ligament (PDL) stress and potential root resorption risk remain unclear. Three-dimensional finite element analysis (3D FEA) provides insight into these factors, but variations in attachments and anchorage strategies merit systematic evaluation. To determine whether molar distalization with clear aligners exceeds the PDL stress thresholds for root resorption and to assess how different attachments and anchorage methods influence stress distribution. Methods: In accordance with the PRISMA 2020 guidelines, four electronic databases were searched without language or date restrictions. Studies were included if they (1) employed 3D FEA, (2) analyzed PDL stress during aligner-based molar distalization, and (3) assessed root resorption risk or stress thresholds. Two reviewers independently screened and extracted data, yielding eight studies. Results: Attachments lowered PDL stress and distributed forces more evenly, reducing root resorption risk compared with no attachment cases. Micro-implants shifted stress to molars and protected anterior teeth; palatal mini-screws achieved greater distalization but higher stress, requiring caution, while buccal mini-screws showed lower stress in first premolar roots. Placing a mini-screw between first and second molars yielded the lowest, most uniform stress. Class II elastics—with precision cuts—demonstrated low compressive stress and improved anchorage, although some resorption risk persisted in maxillary anteriors. Conclusions: Clear aligner–based molar distalization can elevate PDL stress to potentially resorptive levels. Although attachments, micro-implants, and Class II elastics improve stress distribution and lessen root resorption risk, it is not fully eliminated. Careful, individualized treatment planning remains essential, and further clinical validation is needed to establish definitive guidelines.

3 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
GUGabriel Urreola
Gabriel Urreola
MLMichael Nhien Le
Michael Nhien Le
AHAlan Harris
Alan Harris
JCJose Castillo
Jose Castillo
ASAugustine Saiz
Augustine Saiz
RPRichard Price
Richard Price
Background/Objectives: Cannabinoid use is rising among patients undergoing spinal fusion, yet its influence on bone healing is poorly defined. The endocannabinoid system (ECS)—through cannabinoid receptors 1 (CB1) and 2 (CB2)—modulates skeletal metabolism. We reviewed preclinical, mechanistic and clinical evidence to clarify how individual cannabinoids affect fracture repair and spinal arthrodesis. Methods: PubMed, Web of Science and Scopus were searched from inception to 31 May 2025 with the terms “cannabinoid”, “CB1”, “CB2”, “spinal fusion”, “fracture”, “osteoblast” and “osteoclast”. Animal studies, in vitro experiments and clinical reports that reported bone outcomes were eligible. Results: CB2 signaling was uniformly osteogenic. CB2-knockout mice developed high-turnover osteoporosis, whereas CB2 agonists (HU-308, JWH-133, HU-433, JWH-015) restored trabecular volume, enhanced osteoblast activity and strengthened fracture callus. Cannabidiol (CBD), a non-psychoactive phytocannabinoid with CB2 bias, accelerated early posterolateral fusion in rats and reduced the RANKL/OPG ratio without compromising final union. In contrast, sustained or high-dose Δ9-tetrahydrocannabinol (THC) activation of CB1 slowed chondrocyte hypertrophy, decreased mesenchymal-stromal-cell mineralization and correlated clinically with 6–10% lower bone-mineral density and a 1.8–3.6-fold higher pseudarthrosis or revision risk. Short-course or low-dose THC appeared skeletal neutral. Responses varied with sex, age and genetic background; no prospective trials defined safe perioperative dosing thresholds. Conclusions: CB2 activation and CBD consistently favor bone repair, whereas chronic high-THC exposure poses a modifiable risk for nonunion in spine surgery. Prospective, receptor-specific trials stratified by THC/CBD ratio, patient sex and ECS genotype are needed to establish evidence-based cannabinoid use in spinal fusion.

Verified
Journal Article
Open access
PDF file
JCJose Castillo
Jose Castillo
MLMichael Nhien Le
Michael Nhien Le
ARAmanda Ratcliff
Amanda Ratcliff
KSKhadija Soufi
Khadija Soufi
KHKuan-Wei Hunag
Kuan-Wei Hunag
RRRachel Russo
Rachel Russo
Many central nervous system (CNS) disorders lack approved treatment options. Previous research demonstrated that peptide CAQK can bind to chondroitin sulfate proteoglycans (CSPGs) in the extracellular matrix of the CNS. In vivo studies have investigated CAQK conjugated to nanoparticles containing therapeutic agents with varying methodologies/outcomes. This paper presents the first systematic review assessing its properties, applications, and outcomes secondary to its use. Following PRISMA guidelines, a comprehensive search was performed across multiple databases. Studies utilizing CAQK as a therapeutic agent/homing molecule in animal/human models were selected. Sixteen studies met the inclusion criteria. Mice and rats were the predominant animal models. All studies except one used CAQK to deliver a therapeutic agent. The reviewed studies mostly included models of brain and spinal cord injuries. Most studies had intravenous administration of CAQK. All studies demonstrated various benefits and that CAQK conjugation facilitated localization to target tissues. No studies directly evaluated the effects of CAQK alone. The data are limited by the heterogeneity in study methodologies and the lack of direct comparison between CAQK and conjugated agents. Overall, these findings present CAQK utilization to deliver a therapeutic agent as a promising targeting strategy in the management of disorders where CSPGs are upregulated.

22 August 2023 in World Neurosurgery
Verified
Journal Article
Closed access
JCJose Castillo
Jose Castillo
KSKhadija Soufi
Khadija Soufi
FRFreddie Rodriguez
Freddie Rodriguez
Julius O. EbinuJulius O. Ebinu
Julius O. Ebinu

25 November 2024 in Biomed
Verified
Journal Article
Open access
PDF file
JCJose Castillo
Jose Castillo
MLMichael Nhien Le
Michael Nhien Le
CPChristopher D. Pivetti
Christopher D. Pivetti
JJJordan E. Jackson
Jordan E. Jackson
EKEdwin Kulubya
Edwin Kulubya
RRRachel Russo
Rachel Russo
Background: Cervical spinal cord injuries (SCIs) are the most common type of human SCI. Although various animal SCI contusion models have been developed to mirror human pathology, few have described cervical-level injuries. This study aims to validate and establish optimal impact parameters to produce consistent incomplete cervical SCIs for testing novel therapies. Methods: Using a precise impactor, 3 cervical spinal cord hemi-contusions of varying severities were induced by modifying penetration depths and controlling dwell times. Penetration depths of 2.11 mm (n = 4), 2.24 mm (n = 4), and 2.36 mm (n = 3) were used with a dwell time of 0.05 s to create mild, moderate, and severe injuries. Behavioral assessments in weeks 1, 2, 5, and 8 included grooming test, forelimb asymmetry test, and the Irvine, Beatties, and Bresnahan forelimb scale (IBB). After 8 weeks, rats were euthanized, and spinal cord histology was performed. Results: Within each group, animals exhibited consistent motor deficits and functional recovery. Mean IBB scores varied significantly between each group at week 8 (p < 0.0001). Ipsilateral forelimb usage significantly improved throughout the study period in the mild (2.11 mm) and moderate (2.24 mm) groups, while the severely (2.36 mm) injured group continued to exhibit 100% asymmetrical forelimb usage. Conclusions: This study demonstrates that a precise impactor can create reproducible models of incomplete cervical SCIs. A penetration depth of 2.24 mm resulted in moderate injury with significant motor deficits that slowly improved over time, permitting future therapeutic studies in functional recovery.